Literature DB >> 2670321

Lipoproteins and the pathogenesis of atherosclerosis.

D Steinberg, T E Carew, C Fielding, A M Fogelman, R W Mahley, A D Sniderman, D B Zilversmit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2670321     DOI： 10.1161/01.cir.80.3.719

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

1.  Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores.

Authors:  Seyed Reza Najafizadeh; Khatereh Amiri; Maryam Moghaddassi; Shaghayegh Khanmohammadi; Hossein Mirmiranpour; Manouchehr Nakhjavani
Journal:  Clin Rheumatol       Date:  2021-05-28       Impact factor: 2.980

2.  Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  Qi Chen; Steven E Reis; Candace M Kammerer; Dennis M McNamara; Richard Holubkov; Barry L Sharaf; George Sopko; Daniel F Pauly; C Noel Bairey Merz; M Ilyas Kamboh
Journal:  Am J Hum Genet       Date:  2002-11-26       Impact factor: 11.025

3.  Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet.

Authors:  M Miyazaki; H Sakonjo; S Takai
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

4.  A high-density-lipoprotein receptor appears to mediate the transfer of essential fatty acids from high-density lipoprotein to lymphocytes.

Authors:  Q Xu; E Bühler; A Steinmetz; D Schönitzer; G Böck; G Jürgens; G Wick
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

5.  Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide.

Authors:  J D Hayes; D J Judah; L I McLellan; L A Kerr; S D Peacock; G E Neal
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

Review 6.  Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.

Authors:  G L Plosker; S P Clissold
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

7.  Effect of rosuvastatin on concentrations of plasma lipids, urine and plasma oxidative stress markers, and plasma high-sensitivity C-reactive protein in hypercholesterolemic patients with and without type 2 diabetes mellitus: A 12-week, open-label, pilot study.

Authors:  Gen Yoshino; Manabu Tanaka; Saburo Nakano; Tomoko Matsumoto; Masato Kojima; Eiichi Murakami; Toshisuke Morita
Journal:  Curr Ther Res Clin Exp       Date:  2009-12

Review 8.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

Review 9.  HIV protease inhibitors: a review of molecular selectivity and toxicity.

Authors:  Zhengtong Lv; Yuan Chu; Yong Wang
Journal:  HIV AIDS (Auckl)       Date:  2015-04-08

Review 10.  Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.

Authors:  Natalia Milioti; Alexandra Bermudez-Fajardo; Manuel L Penichet; Ernesto Oviedo-Orta
Journal:  Clin Dev Immunol       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.